Literature DB >> 25847931

Molecular profiling is rather likely to be cost effective.

Valesca P Retèl1, Sabine C Linn2, Wim H van Harten3.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25847931     DOI： 10.1200/JCO.2014.59.8029

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  Innovations that reach the patient: early health technology assessment and improving the chances of coverage and implementation.

Authors:  W H van Harten; V P Retèl
Journal:  Ecancermedicalscience       Date:  2016-10-28

2.  Close cooperation with Health Technology Assessment expertise is crucial for implementation and ultimately reimbursement of innovations in oncology.

Authors:  W H van Harten; V P Retèl
Journal:  Ecancermedicalscience       Date:  2016-10-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.